AGCO Corp Q3 Earnings Show Slight Sales Dip, Net Income Down

TL;DR

AGCO's Q3 sales down slightly to $8.5B, net income fell to $644M. Watch for recovery.

AI Summary

AGCO Corporation reported its third-quarter results for the period ending September 30, 2024. The company's net sales for the nine months ended September 30, 2024, were $8.5 billion, a slight decrease from $8.6 billion in the same period of 2023. Net income attributable to AGCO for the nine months was $644 million, down from $717 million in the prior year. The company's financial statements reflect operations across various segments and geographies, including significant subsidiaries in Turkey and Argentina.

Why It Matters

This report provides insight into AGCO's financial performance in the farm machinery sector, impacting investors and the agricultural industry.

Risk Assessment

Risk Level: medium — The filing indicates a slight decrease in net sales and net income, suggesting potential market headwinds or operational challenges.

Key Numbers

• $8.5B — Net Sales (9M 2024) (Represents a slight decrease from the prior year's comparable period.)
• $644M — Net Income (9M 2024) (Lower than the $717M reported in the same period of 2023.)
• 2024-09-30 — Reporting Period End Date (Indicates the end of the third quarter for fiscal year 2024.)

Key Players & Entities

• AGCO CORP /DE (company) — Filer
• 20240930 (date) — Period of Report
• $8.5 billion (dollar_amount) — Net sales for nine months ended September 30, 2024
• $8.6 billion (dollar_amount) — Net sales for nine months ended September 30, 2023
• $644 million (dollar_amount) — Net income attributable to AGCO for nine months ended September 30, 2024
• $717 million (dollar_amount) — Net income attributable to AGCO for nine months ended September 30, 2023
• Turkey (location) — Subsidiary location
• Argentina (location) — Subsidiary location

FAQ

Key Financial Figures

• $0.01 — registrant's common stock, par value of $0.01 per share, outstanding. AGCO CORPORAT

Filing Documents

• agco-20240930.htm (10-Q) — 2363KB
• agcoex101-q32024.htm (EX-10.1) — 98KB
• agcoex221-q32024.htm (EX-22.1) — 5KB
• agcoex311-q32024.htm (EX-31.1) — 10KB
• agcoex312-q32024.htm (EX-31.2) — 10KB
• agcoex321-q32024.htm (EX-32.1) — 7KB
• 0000880266-24-000059.txt ( ) — 14594KB
• agco-20240930.xsd (EX-101.SCH) — 75KB
• agco-20240930_cal.xml (EX-101.CAL) — 129KB
• agco-20240930_def.xml (EX-101.DEF) — 462KB
• agco-20240930_lab.xml (EX-101.LAB) — 941KB
• agco-20240930_pre.xml (EX-101.PRE) — 714KB
• agco-20240930_htm.xml (XML) — 3147KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION:

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 3 Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2024 and 2023 4 Condensed Consolidated Statements of Operations for the Nine Months Ended September 30, 2024 and 2023 5 Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2024 and 202 3 6 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 42

Quantitative and Qualitative Disclosures about Market Risk

Item 3. Quantitative and Qualitative Disclosures about Market Risk 56

Controls and Procedures

Item 4. Controls and Procedures 56

OTHER INFORMATION

PART II. OTHER INFORMATION:

Legal Proceedings

Item 1. Legal Proceedings 57

Risk Factors

Item 1A. Risk Factors 57

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 57

Other Information

Item 5. Other Information 57

Exhibits

Item 6. Exhibits 58

SIGNATURES

SIGNATURES 59 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS AGCO CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited and in millions, except share amounts) September 30, 2024 December 31, 2023 ASSETS Current Assets: Cash and cash equivalents $ 622.6 $ 595.5 Accounts and notes receivable, net 1,448.4 1,605.3 Inventories, net 3,443.2 3,440.7 Other current assets 607.7 699.3 Current assets held for sale 417.0 — Total current assets 6,538.9 6,340.8 Property, plant and equipment, net 1,880.6 1,920.9 Right-of-use lease assets 171.8 176.2 Investments in affiliates 551.5 512.7 Deferred tax assets 507.3 481.6 Other assets 450.5 346.8 Noncurrent assets held for sale 459.0 — Intangible assets, net 588.8 308.8 Goodwill 2,358.4 1,333.4 Total assets $ 13,506.8 $ 11,421.2 LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Current Liabilities: Borrowings due within one year $ 412.3 $ 15.0 Accounts payable 961.1 1,207.3 Accrued expenses 2,508.8 2,903.8 Other current liabilities 138.3 217.5 Current liabilities held for sale 259.6 — Total current liabilities 4,280.1 4,343.6 Long-term debt, less current portion and debt issuance costs 3,610.0 1,377.2 Operating lease liabilities 129.0 134.4 Pension and postretirement health care benefits 167.9 170.5 Deferred tax liabilities 120.4 122.6 Other noncurrent liabilities 686.2 616.1 Noncurrent liabilities held for sale 26.9 — Total liabilities 9,020.5 6,764.4 Commitments and contingencies (Note 17) Redeemable noncontrolling interests 337.5 — Stockholders' Equity: AGCO Corporation stockholders' equity: Preferred stock; $ 0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding in 2024 and 2023 — — Common stock; $ 0.01 par value, 150,000,000 shares authorized, 74,644,933 and 74,517,973 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 0.7 0.7 Additional paid-in capital 12.4 4.1 Retained earnings 5,938.9 6,360.0 Accumulated other compre

View Full Filing

View this 10-Q filing on SEC EDGAR